EU Chemicals Strategy for Sustainability
The Chemicals Strategy for Sustainability (CSS) was recently published by the European Union. The CSS is part of the European Green Deal which aims for a toxic-free environment leading to zero pollution. The initiative proposes a new legislative amend to the EU Cosmetic Products Regulation. Simplification and digitalization of labelling requirements plus review of the definition of nanomaterial are two of the main objectives of the CSS.
Picture of Marta Pinto

Marta Pinto

Regulatory Affairs Associate

TOWARDS A TOXIC-FREE ENVIRONMENT

The European Green Deal sets a high ambition for a toxic-free environment leading to zero pollution. Adopted on 14 October 2020, the European Union (EU) Chemicals Strategy for Sustainability (CSS) outlines the Commission’s strategy for the sustainable and safe use of chemicals. This initiative is part of the Green Deal and aims to better protect human health and the environment while boosting innovation for safe and sustainable chemicals.

The focal point of this initiative are cosmetic products, especially focusing on various actions and potential measures to improve the efficiency and effectiveness of the current rules on these products. Consequently, this strategy will affect the EU Cosmetics Regulation (Regulation (EC) No 1223/2009 on cosmetic products). The CSS includes an institutional commitment of the Commission to present a new legislative proposal to amend the EU Cosmetic Products Regulation.

The Cosmetic Regulation will be subjected to a targeted revision, alongside other chemicals legislation, including REACH Regulation and CLP Regulation. A feedback period for this regulation proposal was set from 4 October until 1 November 2021. The feedback will be considered for further development and fine tuning of the initiative. A synopsis report will be made by the Commission, summarizing the input received and explaining how the input will be taken into account and why certain suggestions could not be considered.

APPROACH AND OBJECTIVES OF THE CSS

According to the European Cosmetic Regulation, substances classified as CMR (carcinogenic, mutagenic or toxic for reproduction) are prohibited in cosmetic products (with exceptions, under strict conditions). Nevertheless, there are other harmful chemicals that may pose similar risks to consumers and professional users. Simultaneous exposure to multiple chemicals (from cosmetics and other sources) may also have harmful effects to the environment and humans. This problem is not currently covered by the requirements of the Cosmetics Regulation. This Regulation is not yet aligned to the approaches announced under the CSS to implement the generic approach to risk management and the essential uses concept intended to address those risks. Therefore, one of the main goals of the initiative is to extend the generic approach to risk management to ensure that cosmetic products do not contain chemicals that:

  • cause cancers, gene mutations, affect the reproductive or the endocrine system (CMRs);
  • affect the immune, neurological or respiratory system;
  • are persistent or bioaccumulative;
  • are toxic to a specific organ.

Extension of the existing and modified provisions restricting CMRs (Article 15 of the Regulation) will be analysed, exceptions’ criteria and processes will be revised and provisions to take account of combination effects will be introduced.

The European Commission’s Scientific Committee on Consumer Safety (SCCS) is responsible for conducting the risk assessments of substances in cosmetics. The CSS wishes to reattribute assessments of substances also used in cosmetics to an EU Agency (e.g., ECHA, new working group of RAC, other independent committee). The CSS approach “One Substance, One Assessment” aims for a better effectiveness, efficiency and coherence of the safety assessments, using the best expertise and resources available in the agencies.

This initiative considers that the EU chemicals legislation needs to use coherent terminology when it comes to the definition of nanomaterial and that this definition should be reviewed and aligned with the outcome of the comprehensive review (Review of the Recommendation 2011/696/EU) taking place in the context of the CSS.

Simplification and digitalization of labelling requirements of chemicals is also taken into account by the CSS initiative, in order to improve the communication of essential information on chemicals. The use of digital tools for product labels is an option.

If you wish to get more information on this subject and the implications of this EU initiative, feel free to contact us at info@criticalcatalyst.com.

References:

  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. Inception Impact Assessment. EU Chemicals Strategy for Sustainability – Revision of the Cosmetic Products Regulation. European Commission. 04/10/2021.
  3. Review of the Recommendation 2011/696/EU – Stakeholder consultation.  European Commission. Available from: https://ec.europa.eu/environment/chemicals/nanotech/review_en.htm

further
reading

cosmetic products

Citral under review: SCCS Preliminary Opinion

The SCCS was tasked by the European Commission to evaluate if the safety levels for Citral, determined through QRA2 based on skin sensitization induction, are sufficient to safeguard consumers. A preliminary opinion was released.

Read More »
cosmetic products

Are sunscreens with Benzophenone-4 safe?

Benzophenone-4 is commonly known as a UV-filter in cosmetic products. Learn what the final opinion of SCCS states about Benzophenone’s safety profile as a UV-filter in cosmetic products.

Read More »
cosmetic products

Is Aluminium in cosmetics safe for human health?

The Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the safety of Aluminium in cosmetic products. This follows a lengthy review process that began in 2013 when the SCCS was first mandated to evaluate the potential health risks of Aluminium (Al) and its compounds in cosmetics.

Read More »
cosmetic products

Silver in Cosmetics: SCCS preliminary opinion.

Ingredients: SILVER

The recent preliminary opinion from the Scientific Committee on Consumer Safety (SCCS) regarding silver in cosmetics is crucial for consumers and manufacturers. This article breaks down the key points, making it easier to understand the implications and stay informed.

Read More »
news & updates

EU Ecolabel adoption and recognition are on the rise

The Ecolabel certification is a comprehensive program focused on fostering sustainable practices. It evaluates products based on life cycle assessments, where every phase of said life cycle must abide by strict standards to attain the Ecolabel certification. The overarching objective of this certification is minimizing environmental harm from production or consumption activities.

Read More »
cosmetic products

UK proposes ban of wet wipes containing plastic 

The UK has proposed, on April 24, 2024, a regulation titled The Environmental Protection (Wet Wipes Containing Plastic) (England) Regulations 2024, to the World Trade Organization (WTO). The regulation aims to eliminate the supply and sale of plastic-containing wet wipes, including cosmetic ones. The public can offer comments on the draft until June 23, 2024, with adoption expected in September of the same year.

Read More »
news & updates

SCCS preliminary opinion on Citral sensitization endpoint

Ingredients: CITRAL

Date of publication: 27/03/2024

On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Citral in cosmetic products. The deadline for comments is set to June 2, 2024.

Read More »
medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »